<!DOCTYPE html>

<html lang="fa">
<meta content="text/html;charset=utf-8" http-equiv="content-type"/>
<head><title>Treatment of deep burns</title><link href="/z/d/css/bootstrap.min.css" rel="stylesheet"/><link href="/z/d/css/icofont.min.css" rel="stylesheet"/><link href="/z/d/css/classy-nav.min.css" rel="stylesheet"/><link href="/z/d/css/animate.css" rel="stylesheet"/><link href="/z/d/css/owl.carousel.css" rel="stylesheet"/><link href="/z/d/css/magnific-popup.css" rel="stylesheet"/><link href="/z/d/css/owl.theme.default.min.css" rel="stylesheet"/><link href="/z/d/css/style.css" rel="stylesheet"/><link href="/z/d/css/rtl_edited.css" rel="stylesheet"/><link href="/z/d/css/responsive.css" rel="stylesheet"/><link href="https:///uptodate_assets/main.css" rel="stylesheet"/>
<style>

#myUL {
  list-style-type: none;
  padding: 0;
  margin: 0;
}

#myUL li a {
  border: 1px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #f6f6f6;
  padding: 12px;
  text-decoration: none;
  font-size: 16px;
  color: black;
  display: block
}

#myUL li a:hover:not(.header) {
  background-color: #eee;
}

#searchResult {

  list-style-type: none;
  padding: 0;
  padding-right: 20px;
}

#searchResult li a {
  border: .5px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #79bc21;
  padding: 7px;
  text-decoration: none;
  font-size: 14px;
  color: white;
  display: block
}

#searchResult li a:hover:not(.header) {
  background-color: #222;
}


#txtHint   {
  position: absolute;
  text-shadow: none;
  width: 100%;
  margin-top: -15px;
  padding-right: 10px;

  filter: alpha(opacity=95);
  -moz-opacity: 0.95;
  opacity: 1;
  z-index: 200;
}
.countBubl {
  background:#eb0029;
  color:#fff;
  padding:5px;
  margin-top: 50%;

}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(2) {
 width: 55%;
 padding-left: 20px;
}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(3) {
 width: 20%;
}
 #Uptodate_image {
      width: 50%;
  }#uptodate-area {
      /*z-index: 99;*/
  }
#uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > div:nth-child(2) {
 margin-left: 10px;
 margin-bottom: 6%;
}
@media (max-width: @screen-xs) {
    .countBubl {
        font-size: 4px ;
    }
    #uptodate_version {
        font-size: 4px ;
    }
}

@media (max-width: @screen-sm) {
    .countBubl {
        font-size: 14px ;
    }
}
@media  all and(max-width: 820) {
    #Uptodate_image {
        width: 80% ;
    }#uptodate-area {
        z-index: 99;
    }
}@media  all and (min-width: 820) and(max-width: 88820){
    #Uptodate_image {
        width: 100% !important;
    }
    .countBubl {
        font-size: 4px ;
    }
}
div.col-md-3:nth-child(3) {
 margin-top: 6%;
}

div.col-md-3:nth-child(3) > img:nth-child(1) {
 width: 100%;
 margin-left: 11px;
}

</style>
<style media="screen" type="text/css">
  .goback {
    width: 200px;
    height: 40px;
    line-height: 40px;
    position: fixed;
    display: none;
    font-size: 15px;
    background: #71c0fa;
    z-index: 1000;
    text-align: center;
    color: #ffffff;
    -webkit-border-radius: 1px;
    -moz-border-radius: 1px;
    border-radius: 50px;
    bottom: 3.8%;
    right: 2%;
}
  .buyPackage {
  width: 100px;
  height: 100px;
  line-height: 40px;
  position: fixed;
  display: none;
  font-size: 10px;
  background: #fa759e;
  z-index: 1000;
  text-align: center;
  color: #ffffff;
  -webkit-border-radius: 1px;
  -moz-border-radius: 1px;
  border-radius: 10px;
  top: 150px;
  right: 2%;
  text-align: center;
}
.uptodate-area {
  /*background-image: url(../../assets/img/news-letter-bg.jpg);*/
  background-position: center center;
  background-size: cover;
  background-repeat: no-repeat;
    background-attachment: fixed;
  position: relative;
}
.uptodate-area::before {
  content: '';
  position: absolute;
  left: 0;
  padding-top: 100px;
  width: 100%;
}
#references{
  display: none;
}
</style>
<style>
section.sticky {
  position: sticky;
  top: 0;
  background-color: #fff !important;
  /*z-index: 100;*/
  /*padding-top: 80px;*/

}
.m4inb{
    border: solid !important;
  }

  .newsletter-area::before {
       background: unset !important;
  }
p {
    color: #555;
}
</style>
<meta content="" name="description"/>
<link href="/z/d/img/favicon.png" rel="icon" type="image/png">
</link></head>
<body>
<!-- Start Main Menu Area -->
<br/>
<br/>
<br/>
<br/>
<div class="container">
<div class="row">
</div>
</div>
<section class="teacher-area ptb-10">
<div class="container">
</div>
<section class="course-details-area ptb-60">
<div class="container">
<div class="uptodate2" style="padding:50px 0px 50px 0px;direction: ltr;text-align: left;">
<h1 style="text-align:center">Treatment of deep burns</h1>
<div class="utdArticleSection utdStyle" id="topicContent"><div id="topicTitle">Treatment of deep burns</div> <div class="authorSectionElem"><div class="authorsElementsLeft"><dl id="topicContributors"><dt><span> </span>Authors:</dt><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Herb A Phelan, MD, MSCS</a></dd><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Eileen Bernal, MD</a></dd><dt><span> </span>Section Editor:</dt><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Marc G Jeschke, MD, PhD</a></dd><dt><span> </span>Deputy Editor:</dt><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Kathryn A Collins, MD, PhD, FACS</a></dd></dl></div><div class="authorsElementsRight"><div id="literatureReviewDate"><div class="litReviewSingleLine"><bdi><span class="emphasis">Literature review current through:</span> Jan 2024.</bdi></div><div class="litReviewSingleLine"><bdi><span class="emphasis">This topic last updated:</span> May 18, 2022.</bdi></div></div></div></div><div id="topicWhatsNewContainer"></div><div id="topicText"><p class="headingAnchor" id="H2977013862"><span class="h1">INTRODUCTION</span><span class="headingEndMark"> — </span>A burn converts normal intact skin into an open wound. The primary goal of burn wound care is wound closure. While cleansing, debridement, and local wound care may be sufficient for healing superficial burns (epidermal [superficial], superficial partial thickness), deep burns (deep partial thickness, full thickness, or deeper) require surgical excision and skin grafting. The earlier this can be accomplished, the more expedited the recovery. </p><p>The assessment, initial treatment, and excision and closure of deep burn wounds is reviewed here. The treatment of superficial burns is reviewed separately. (See  <a class="medical medical_review" href="/z/d/html/349.html" rel="external">"Treatment of minor thermal burns"</a> and  <a class="medical medical_review" href="/z/d/html/6624.html" rel="external">"Sunburn"</a> and  <a class="medical medical_review" href="/z/d/html/114176.html" rel="external">"Treatment of superficial burns requiring hospital admission"</a>.)</p><p class="headingAnchor" id="H3769167865"><span class="h1">INITIAL CARE</span><span class="headingEndMark"> — </span>Burns are considered traumatic injuries, and initial trauma assessment is similar, with evaluation of airway, breathing, and circulation. While some small total body surface area (TBSA) deep burn injuries can be managed in the outpatient setting at the discretion of the burn surgeon, most deep burn injuries will require admission to a burn intensive care unit. Larger TBSA burns (&gt;20 percent) are associated with calculated large fluid resuscitation expectations, with predictable tissue edema affecting not only cutaneous structures but the airway as well. It is prudent to consider elective intubation in patients with &gt;30 percent TBSA deep burn before airway compromise occurs; however, in patients at the extremes of age or with comorbid conditions, a decision to electively intubate should be considered with burns &lt;30 percent TBSA. (See  <a class="medical medical_review" href="/z/d/html/16320.html" rel="external">"Overview of the management of the severely burned patient", section on 'Emergency burn care'</a>.)</p><p class="headingAnchor" id="H932090849"><span class="h2">Burn wound characterization</span><span class="headingEndMark"> — </span>Decisions for fluid resuscitation and surgical decision making depend on acute characterization of the burn wounds. </p><p class="bulletIndent1"><span class="glyph">●</span>Burn depth – The depth of tissue injury is clinically based on the classification system for cutaneous burn wounds given in the table  (<a class="graphic graphic_table graphicRef57124" href="/z/d/graphic/57124.html" rel="external">table 1</a> and <a class="graphic graphic_figure graphicRef73309" href="/z/d/graphic/73309.html" rel="external">figure 1</a>). (See <a class="local">'Accuracy of bedside assessment'</a> below and  <a class="medical medical_review" href="/z/d/html/819.html" rel="external">"Assessment and classification of burn injury", section on 'Classification by depth'</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>TBSA – Initial estimation of the burn size as a percentage of the TBSA is crucial for triage, initial assessments and treatments, and anticipated long-term management, and is also used in referral criteria. Traditional methods of estimation are based on clinical assessments, but future methods may include specific imaging technology that uses drawings or photographs for calculations [<a href="#rid1">1</a>]. The most widely used tools are the Wallace Rule of Nines [<a href="#rid2">2</a>], the Rule of Palm [<a href="#rid3">3</a>], and use of a Lund and Browder Chart  (<a class="graphic graphic_table graphicRef50237" href="/z/d/graphic/50237.html" rel="external">table 2</a> and <a class="graphic graphic_figure graphicRef71190" href="/z/d/graphic/71190.html" rel="external">figure 2</a>) [<a href="#rid4">4</a>]. These are reviewed in more detail separately. (See  <a class="medical medical_review" href="/z/d/html/819.html" rel="external">"Assessment and classification of burn injury", section on 'Extent of burn injury'</a>.)</p><p></p><p>Clinically, the time to healing and development of scarring are also used to characterize burns; the longer the time to heal, the more likely the burn wound will be associated with scarring. Deep burn injuries invariably cause moderate-to-severe scarring. (See  <a class="medical medical_review" href="/z/d/html/95111.html" rel="external">"Hypertrophic scarring and keloids following burn injuries", section on 'Incidence and risk factors'</a>.)</p><p class="headingAnchor" id="H2652706952"><span class="h3">Accuracy of bedside assessment</span><span class="headingEndMark"> — </span>Bedside clinical assessment is the most widely used and cost-effective method to characterize burn depth. This subjective assessment is based upon characteristics that are easily observed  (<a class="graphic graphic_figure graphicRef73309" href="/z/d/graphic/73309.html" rel="external">figure 1</a>) without the need for any advanced instrumentation and is most reliable for very shallow burns or very deep burns but can be inaccurate in up to one-third of diagnoses of burns of intermediate depth (ie, superficial versus deep partial-thickness burns) [<a href="#rid5">5,6</a>]. </p><p>There is considerable variation between different clinicians, which reduces reliability of clinical burn depth characterization [<a href="#rid7">7-9</a>]. The most common inaccuracies are from overestimation of the burn depth [<a href="#rid10">10</a>]. Newer developments in burn depth assessment focus on measurements of tissue perfusion and may help expedite earlier recognition of deeper burns to facilitate expeditious excision [<a href="#rid11">11</a>]. </p><p class="headingAnchor" id="H686411893"><span class="h3">Burns awaiting demarcation</span><span class="headingEndMark"> — </span>Certain clinical features that distinguish between partial-thickness and full-thickness burns may not be obvious acutely, necessitating serial evaluations and time. As an example, a full-thickness burns may appear pale or patchy initially, rather than white or gray. Any burn that appears to be either deep partial thickness or full thickness is considered full thickness until more accurate differentiation is possible. </p><p class="headingAnchor" id="H1879812346"><span class="h3">Conversion to deeper burn injury</span><span class="headingEndMark"> — </span>Optimizing burn wound care can be challenging in the face of burn wound conversion, which is a progression of a superficial partial-thickness burn to a deep partial-thickness or full-thickness burn. The pathophysiology of burn wound conversion is multifactorial and varies between patients [<a href="#rid12">12</a>]. One early pathogenesis described conversion through three concentric zones of burn injury: an irrevocably damaged area of coagulation, a threatened but still viable zone of stasis, and an edematous zone of hyperemia. Burn wound conversion is thought to occur as tissue in the zone of stasis denatures, increasing burn depth [<a href="#rid13">13</a>]. </p><p class="headingAnchor" id="H3614615639"><span class="h2">Escharotomy</span><span class="headingEndMark"> — </span>Escharotomies are often indicated for deep partial- and full-thickness burns, mostly when associated with &gt;20 percent TBSA burn. Escharotomies may be performed at the time of initial burn presentation, particularly among those with circumferential burns; however, escharotomy may be needed at a later time as tissue edema increases with fluid resuscitation. Severe tissue edema may compromise vascular flow, potentially leading to compartment syndromes related to the external compression. (See  <a class="medical medical_review" href="/z/d/html/2889.html" rel="external">"Abdominal compartment syndrome in adults"</a> and  <a class="medical medical_review" href="/z/d/html/358.html" rel="external">"Acute compartment syndrome of the extremities"</a>.)</p><p>Vigilant monitoring of distal pulses or Doppler signals, bladder pressure, and peak airway pressures is mandatory when assessing the need for escharotomy of the extremities, abdomen, or chest, respectively. The procedure decompresses the subcutaneous tissue to prevent secondary ischemia. Escharotomy can be performed expeditiously at the bedside either in the emergency department or in the intensive care unit, rarely requiring travel to the operating room. Escharotomy can be performed using a scalpel, but electrocautery decreases blood loss. Longitudinal incisions are made along the entire length of the full-thickness eschar, which increases the compliance of the cutaneous tissue [<a href="#rid14">14</a>]. The open escharotomy wound is dressed with saline-moistened gauze as described below. (See <a class="local">'Initial wound care and dressings'</a> below.)</p><p>While rapid, safe, and effective, escharotomy is not without risk, and complications are more likely when it is performed by inexperienced physicians. Complications include hemorrhage, increased fluid loss, subcutaneous infection, and neuromuscular injury [<a href="#rid15">15,16</a>]. Failure to perform an adequate escharotomy can lead to irreversible tissue ischemia. </p><p class="headingAnchor" id="H3519711718"><span class="h2">Ongoing fluid therapy</span><span class="headingEndMark"> — </span>Formal fluid resuscitation is typically limited to patients with &gt;20 percent TBSA burn, but special considerations are made in patients at the extremes of age who may otherwise benefit. Oral hydration is usually sufficient in patients with &lt;20 percent TBSA [<a href="#rid17">17</a>], with the addition of a maintenance intravenous fluid rate, if needed. The authors' preferred approach in severely burned patients is to use the Parkland formula to calculate initial fluid resuscitation needs (ie, crystalloid volume). Colloid, specifically albumin, is administered as a rescue method for nonresponders (ie, patients with increasing crystalloid requirements without the expected clinical improvement or without adequate urine output) and plasma for correction of coagulopathy. </p><p>Several formulas (eg, Parkland, modified Brooke, Rule of Tens) exist whereby the volume of fluid resuscitation is a function of the total body surface area burned and the weight of the patient. Regardless of the formula used to calculate fluid resuscitation parameters, all are considered a starting point [<a href="#rid18">18</a>]. (See  <a class="medical medical_review" href="/z/d/html/350.html" rel="external">"Emergency care of moderate and severe thermal burns in adults", section on 'Estimating initial fluid requirements'</a>.)</p><p>Real-time data and parameters are used to guide ongoing resuscitation, which may differ from initial formula calculations. All patients undergoing formal fluid resuscitation should have a urinary catheter inserted for accurate measurement of hourly urine output. Specifically, urine output is an easily observable parameter, and approximately 0.5 to 1 mL of urine per hour per kilogram of the patient's weight is considered a marker of successful resuscitation; similarly, 30 to 35 mL/hour for average-sized adults is also within acceptable range [<a href="#rid19">19</a>]. Hourly urine output for pediatric patients should be in the range of 1 to 2 mL/kg/hour. </p><p>The authors' preferred formula in the management of severe burn injury is the Parkland formula, which uses a factor of four for calculating initial fluid resuscitation needs: 4 mL of intravenous fluid for every kilogram of the patient's weight multiplied by the total percent TBSA (not including epidermal [superficial burns])  (<a class="graphic graphic_figure graphicRef97077" href="/z/d/graphic/97077.html" rel="external">figure 3</a>). Of this volume, one-half is given in the first eight hours after burn injury, and the remaining one-half over the subsequent 16 hours. Initiation of the specific rate per the formula is used; fluid boluses are not indicated unless there are other hemodynamic indications. It is important to note that the formula includes time from burn injury. Any fluid given before the calculation is made should be subtracted from the expected volume to be given in the first eight hours; otherwise, higher volumes than necessary may be administered. Fluid calculations should also be adjusted once TBSA assessments are made by more experienced personnel; specifically, the TBSA reported by emergency medical services is often incorrect. </p><p>The fluids used in the Parkland formula included crystalloid, specifically <a class="drug drug_general" data-topicid="108196" href="/z/d/drug information/108196.html" rel="external">Lactated Ringer</a>'s (LR) solution, as well as albumin infusion both at a particular time and specific rate. The original Parkland formula accounted for a predictable timing of albumin bolus at the conclusion of a 24-hour resuscitation period at a rate of (0.1 cc) x (TBSA) x (kg). The occurrence of fluid creep (resuscitation volumes that exceed those predicted) has led to some alteration in this method, specifically using colloid infusion as a means of "rescue therapy" or a way to halt or decrease fluid creep [<a href="#rid20">20</a>]. The administration of colloid, specifically albumin, during the initial resuscitative phase was evaluated in the past, but studies were small, and results and recommendations have been conflicting [<a href="#rid21">21</a>]. Contemporary studies have proposed reevaluation of plasma administration for burn resuscitation. Plasma was previously avoided due to the risk of transmission of bloodborne disease, cost, and risks of transfusion-related reactions (ie, transfusion-related acute lung injury, transfusion-associated circulatory overload, allergy) [<a href="#rid22">22</a>]. </p><p>Fluid creep refers to fluid resuscitation volumes that exceed those predicted by the Parkland formula, specifically in larger TBSA burns [<a href="#rid23">23</a>]. Colloid infusion may help decrease the complications of fluid creep, even if the specific cause is not addressed. In one systematic review, a meta-analysis of four trials, mean load (volume [mL]/percent TBSA/weight [kg]) 24 hours following burn injury was lower for hyperosmotic fluid compared with isosmotic fluid (LR) without altering renal function or mortality [<a href="#rid24">24</a>]. The hyperosmotic fluids included hypertonic <a class="drug drug_general" data-topicid="9929" href="/z/d/drug information/9929.html" rel="external">saline</a>, or LR plus albumin, fresh frozen plasma, or hydroxyethyl starch. Additional trials are needed to determine whether any of the hyperosmotic fluids result in better outcomes than the others. However, it should be noted that among 25 trials in a separate systematic review, hydroxyethyl starch increased the risk of death compared with crystalloid (risk ratio 1.10, 95% CI 1.02-1.19) [<a href="#rid25">25</a>]. </p><p>Some degree of early fluid restriction, especially with close goal-directed therapy, can also help decrease the incidence of fluid creep. Some examples of colloid use to help decrease the incidence and impact of fluid creep include: </p><p class="bulletIndent1"><span class="glyph">●</span>Adherence to the original Parkland formula with a routine colloid bolus at the completion of a 24-hour crystalloid fluid resuscitation [<a href="#rid20">20</a>]. </p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Initiation of resuscitation with albumin at 12 hours post-burn when fluid requirements exceed 120 percent of normal [<a href="#rid26">26</a>]. </p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Use of 5% albumin infusion in any patient whose 24-hour fluid resuscitation requirements are projected to exceed 6 mL/kg/% TBSA [<a href="#rid27">27</a>].</p><p></p><p>Responders to fluid resuscitation are those patients in whom urine output remains within the acceptable range during the first 24 hours, while nonresponders are those who fall short of this expectation or are oliguric. It is important to identify these nonresponders early because there is a potential tendency to increase the hourly resuscitation volume, which may lead to significant pulmonary and cardiac consequences without any additional benefit. While some patients may adhere to their calculated 24-hour fluid resuscitation volumes with expected urine output, some may have higher- or lower-than-expected urine output. Both scenarios require specific attention. </p><p class="bulletIndent1"><span class="glyph">●</span>In a patient with excess urine output, consideration may be made to decrease the hourly fluid resuscitation to help prevent unnecessary volume overload. Some possible etiologies of this supraoptimal response may be due to an overestimation of either TBSA or burn depth. (See <a class="local">'Burn wound characterization'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>A patient with suboptimal urine output may benefit from intermittent increases in hourly resuscitation volume as long as there is a parallel increase in urine output. However, close attention is mandatory to avoid excessive increases without a comparable response to urine output; these specific nonresponders are candidates for earlier continuous renal replacement therapy. (See  <a class="medical medical_review" href="/z/d/html/1845.html" rel="external">"Continuous kidney replacement therapy in acute kidney injury"</a>.)</p><p></p><p class="headingAnchor" id="H1815298764"><span class="h2">Initial wound care and dressings</span><span class="headingEndMark"> — </span>Ultimately, the management of deep burn injury requires excision of the eschar; any local therapy applied before excision occurs is unlikely to have significant effect. Specifically, while antibiotic-impregnated or silver-containing products are useful in superficial burns after cleansing/debridement [<a href="#rid28">28</a>], the thick eschar of deep partial-thickness and full-thickness burns prevents penetration of the compounds, and they are generally not indicated. Ultimately, the eschar must be removed before any dressing can be effective, and therefore dry gauze is sufficient on unexcised eschar, with plans for excision as soon as possible. Wound management following burn wound excision and dressings following skin grafting are discussed below. (See  <a class="medical medical_review" href="/z/d/html/13509.html" rel="external">"Topical agents and dressings for local burn wound care"</a> and <a class="local">'Post-excision dressings'</a> below and <a class="local">'Graft dressings'</a> below.)</p><p>For deep partial-thickness or full-thickness burns associated with escharotomies, saline-moistened gauze should be placed within the incisions to prevent desiccation of the subcutaneous tissue. Similarly, exposed tendon, bone, and muscle should also be kept moist. (See  <a class="medical medical_review" href="/z/d/html/15912.html" rel="external">"Basic principles of wound management", section on 'Wound dressings'</a>.) </p><p>Burn wound care is routinely accomplished in the burn unit, often in a special treatment room, but in some burn centers, the initial wound care is completed in the operating room with general endotracheal anesthesia. For patients who are not undergoing general anesthesia, analgesia for the burn wound cleansing can be achieved with intravenous administration of narcotics and anxiolytics (eg, <a class="drug drug_general" data-topicid="9788" href="/z/d/drug information/9788.html" rel="external">morphine</a> and benzodiazepines) with timed oral narcotics (ie, <a class="drug drug_general" data-topicid="91299" href="/z/d/drug information/91299.html" rel="external">hydrocodone</a>) within 30 minutes prior to cleansing. These medications are started just shortly beforehand when the patient and personnel are ready to proceed. (See  <a class="medical medical_review" href="/z/d/html/264.html" rel="external">"Procedural sedation in adults in the emergency department: General considerations, preparation, monitoring, and mitigating complications"</a> and  <a class="medical medical_review" href="/z/d/html/6330.html" rel="external">"Procedural sedation in children: Approach"</a>.)</p><p>Once analgesia is achieved, cleaning deep burn wounds with sterile <a class="drug drug_general" data-topicid="9929" href="/z/d/drug information/9929.html" rel="external">saline</a> or Dakin’s solution (0.025% sodium hypochlorite) is generally sufficient to remove debris [<a href="#rid29">29</a>]. Scrubbing with povidone/iodine solution (Betadine), <a class="drug drug_general" data-topicid="9244" href="/z/d/drug information/9244.html" rel="external">chlorhexidine</a> (Peridex), or other agents is not typically necessary [<a href="#rid30">30</a>]. (See  <a class="medical medical_review" href="/z/d/html/13509.html" rel="external">"Topical agents and dressings for local burn wound care"</a>.)</p><p class="headingAnchor" id="H3392445810"><span class="h1">EARLY BURN EXCISION</span><span class="headingEndMark"> — </span>Deep burn injuries require excision of burn eschar to provide an appropriate wound bed for eventual autografting, prevent burn wound sepsis, and simplify dressing changes [<a href="#rid31">31,32</a>]. Based upon small randomized trials and observational studies [<a href="#rid33">33-38</a>], we suggest early burn wound excision, which removes ischemic, necrotic, and potentially infected tissue, rather than awaiting eschar separation (see <a class="local">'Efficacy'</a> below). Following burn wound excision, skin/soft tissue coverage can be performed concurrently if adequate tissue is available. At other times, temporary wound dressings or other alternatives (eg, skin substitutes) are needed until more definitive reconstruction can be accomplished. (See  <a class="medical medical_review" href="/z/d/html/13509.html" rel="external">"Topical agents and dressings for local burn wound care"</a> and <a class="local">'Burn wound closure'</a> below.)</p><p>Prior to the recognition that early excision reduced burn wound mortality and complications, burn eschar was left undisturbed until it spontaneously separated from the underlying wound bed, revealing granulation tissue suitable for grafting. Burn wound sepsis was a common consequence due to the prolonged process. While topical agents applied to the eschar were used as a means to control the level of bacterial colonization, these were essentially ineffective since the typical agents (eg, <a class="drug drug_general" data-topicid="9579" href="/z/d/drug information/9579.html" rel="external">mafenide</a> acetate, aqueous <a class="drug drug_general" data-topicid="9888" href="/z/d/drug information/9888.html" rel="external">silver nitrate</a> solution, <a class="drug drug_general" data-topicid="9890" href="/z/d/drug information/9890.html" rel="external">silver sulfadiazine</a>) do not penetrate the eschar [<a href="#rid39">39-45</a>]. (See <a class="local">'Initial wound care and dressings'</a> above and  <a class="medical medical_review" href="/z/d/html/13509.html" rel="external">"Topical agents and dressings for local burn wound care"</a> and  <a class="medical medical_review" href="/z/d/html/14985.html" rel="external">"Burn wound infection and sepsis"</a>.)</p><p>Hemodynamic and resuscitative parameters must be under control for the patient to tolerate general anesthesia and the stress of excision and grafting, including what is often large blood volume loss during and after excision of large total body surface area (TBSA) burns. (See  <a class="medical medical_review" href="/z/d/html/94580.html" rel="external">"Anesthesia for patients with acute burn injuries"</a>.)</p><p>Early burn wound excision and closure alone does not eliminate the hypermetabolic response [<a href="#rid46">46,47</a>]. (See  <a class="medical medical_review" href="/z/d/html/818.html" rel="external">"Hypermetabolic response to moderate-to-severe burn injury and management"</a>.)</p><p class="headingAnchor" id="H1877120833"><span class="h2">Efficacy</span><span class="headingEndMark"> — </span>Early excision of necrotic tissue and closure of the burn wound was one of the greatest advancements in the treatment of patients with severe burn injuries and is a mainstay of modern therapy [<a href="#rid37">37,38</a>]. </p><p>In an early single-institution review of 1103 patients, mortality declined significantly from before to after early eschar excision and burn wound closure was standardized as practice (24 to 7 percent; 1974 to 1979-1984) [<a href="#rid37">37</a>]. The mortality reduction was independent of burn size, patient age, and sex. The most dramatic reduction in mortality occurred in older patients with massive burn injuries. In a later meta-analysis of four trials (490 patients), there was a nonsignificant trend toward lower mortality in patients managed with early excision compared with conservative treatments consisting of dressing changes, and placement of skin grafts following eschar separation (relative risk [RR] 0.72; 95% CI 0.52-1.01). Patients in the early excision group had greater transfusion requirements (standard mean difference [SMD] 1.65; 95% CI 0.51-2.80), but hospital length of stay was shorter (SMD -8.89; 95% CI -14.28 to -3.50). The trials included in the meta-analysis were generally low quality (high risk of bias). </p><p>For some anatomic sites, such as the hand, optimal management remains debated [<a href="#rid48">48,49</a>]. (See  <a class="medical medical_review" href="/z/d/html/825.html" rel="external">"Primary operative management of hand burns"</a>.) </p><p class="headingAnchor" id="H50047460"><span class="h2">Timing</span><span class="headingEndMark"> — </span>Excision should ideally be within 24 to 72 hours of the burn injury, but whether this is feasible depends heavily on the condition of the patient in that time frame. The ideal timing to grafting is immediate if the wound bed can be appropriately prepared. In a review evaluating burn wound care in 3561 burn patients over a 14-year period, significant decreases in mortality (9.8 versus 7.3 percent) and length of hospital stay (23 days in 1979 to 14.2 days in 1990) were correlated with a decrease in the surgery interval (14.8 days in 1979 to 6.1 days in 1990) [<a href="#rid50">50</a>]. The surgery interval reflected the rapidity with which the surgical team was able to close the burn wound.</p><p>For small TBSA wounds, excision and grafting can be performed within this time frame, but for large TBSA burns, hemodynamics and progress with resuscitation must be taken into account before subjecting the patient to the acute blood loss expected during the burn wound excision procedure. </p><p class="headingAnchor" id="H2433851818"><span class="h2">Techniques</span><span class="headingEndMark"> — </span>The thick eschar that characterizes deep burn injury requires complete excision to create a wound bed appropriate for the acceptance of autografts or other biologic dressings. Most described techniques for surgical excision of deep burn injuries involve sharp debridement and excision, typically with an excision knife or other cutting instrument (ie, dermatome), but other methods are being developed as alternatives. </p><p class="headingAnchor" id="H2289922971"><span class="h3">Tangential excision</span><span class="headingEndMark"> — </span>Tangential excision is the most common technique and involves sequential debridement of burned tissue until a layer of viable, vascularized tissue is encountered [<a href="#rid51">51</a>]. Tangential excision may suffice for superficial partial-thickness burn wounds, whereas for deep partial-thickness and full-thickness burn wounds, full-thickness excision is required to assure an adequate tissue bed to accept an autograft. </p><p class="headingAnchor" id="H3473071470"><span class="h4">Sharp</span><span class="headingEndMark"> — </span>A sharp handheld instrument is usually used. One of these is the Humby knife, which is a long, guarded blade that can be adjusted to the depth of excision needed [<a href="#rid52">52</a>]. Another instrument is the Goulian-Weck dermatome. Both apply pressure against the burn wound to assure sequential excision of even depths of tissue. The instrument is guided across the burn eschar in a back-and-forth motion with downward pressure and little forward force to produce a smooth excision. Care must be taken as too great a pressure will lead to uneven excision, potential excision of otherwise viable tissue, or inadvertent excision deeper than was planned [<a href="#rid53">53</a>]. </p><p>Excision to an easily identified fascial plane is typically reserved for very large, deep, and life-threatening burn wounds; invasive burn wound sepsis; or when the patient is unlikely to tolerate the very large blood volume loss of tangential excision. The main drawback is permanent loss of cutaneous sensation and development of lymphedema with the excision of viable subcutaneous tissue and lymphatics [<a href="#rid54">54,55</a>]. In addition, fascial excision leads to notable tissue depression with unaesthetic contour deformities. </p><p class="headingAnchor" id="H2983717687"><span class="h4">Hydrosurgery</span><span class="headingEndMark"> — </span>Another technique for burn wound excision that can be applied to partial thickness burns uses high-pressure water jets to debride necrotic tissue (eg, Versajet [<a href="#rid51">51,56,57</a>]). Proponents of hydrosurgery have noted that it can help preserve dermal tissue, which should reduce scarring [<a href="#rid58">58,59</a>]. One randomized trial has reported encouraging results; however, additional larger trials with longer term follow-up are needed before making a recommendation for routine use. Availability of this technology may be limited.</p><p>In a within-patient trial, among 137 patients who required split-thickness skin grafting, the burn wound in one area was excised with hydrosurgical techniques, and in another area conventional debridement was performed using a Weck knife [<a href="#rid60">60</a>]. At 12 months, Patient and Observer Scar Assessment Scale (POSAS) observer total item score, which judges vascularity, pigmentation, thickness, relief, pliability, and surface area, was significantly lower for hydrosurgically debrided wounds (mean difference -0.16, 95% CI -0.25 to -0.06), as was observer overall opinion score (mean difference -0.22, 95% CI -0.34 to -0.09). Patient total item score was also lower (mean difference -0.29, 95% CI -0.49 to -0.09), but patient overall opinion score was not. Among patients who noticed a difference, twice as many judged the hydrosurgically debrided area to be better or much better at 12 months; however, one-fourth of patients saw no difference. Histologically, significantly more dermis was preserved with hydrosurgery. Complication rates did not differ between both treatments. </p><p class="headingAnchor" id="H3710518805"><span class="h3">Others</span><span class="headingEndMark"> — </span>Various types of selective enzymatic debridement have also been used [<a href="#rid61">61</a>]. As an example, NexoBrid (EDNX) has specific debriding enzymatic activity that is derived from bromelain raw material extracted from pineapple plant stems [<a href="#rid62">62</a>]. In one randomized controlled clinical trial, NexoBrid significantly reduced the time from injury to complete debridement, need for surgery, area of burn excised, and need for autografting [<a href="#rid63">63</a>]. </p><p class="headingAnchor" id="H3752989670"><span class="h2">Hemostasis</span><span class="headingEndMark"> — </span>Tangential excision is traumatic and associated with significant blood loss as excision continues until a layer of viable, bleeding tissue is encountered. Blood loss can be lessened with the use of tourniquets on extremities and topical hemostatic agents on the wound bed. Tumescent solution with <a class="drug drug_general" data-topicid="9409" href="/z/d/drug information/9409.html" rel="external">epinephrine</a> can also be used before eschar and donor site excision to decrease bleeding [<a href="#rid54">54</a>].</p><p class="bulletIndent1"><span class="glyph">●</span>Tourniquets for extremity burns – The use of tourniquets, with or without Esmarch bandages, has been used in the excision of deep partial- and full-thickness burns of the extremities to help reduce blood loss [<a href="#rid64">64</a>]. Tourniquets are used only when grafting is anticipated immediately after excision and does not affect graft take. It is unnecessary for staged procedures where excision and grafting are separated temporally. One drawback to tourniquet use during excision is that exsanguination of an extremity limits capillary bleeding, which is useful as a marker to distinguish viable from nonviable tissue, which could lead to excessive tissue excision [<a href="#rid65">65</a>]. As with tourniquets used in other surgical procedures, tourniquet time should be limited; approximately 30 minutes is an acceptable duration. </p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Topical hemostatic agents – Fibrin sealants have been used in burn operations for both their hemostatic and adhesive properties, and often in combination with tourniquet exsanguination of the extremities. [<a href="#rid66">66-69</a>] (See  <a class="medical medical_review" href="/z/d/html/15118.html" rel="external">"Skin autografting", section on 'Graft placement and fixation'</a> and  <a class="medical medical_review" href="/z/d/html/7938.html" rel="external">"Fibrin sealants"</a>.)</p><p></p><p class="headingAnchor" id="H480499533"><span class="h2">Post-excision dressings</span><span class="headingEndMark"> — </span>Following excision, if grafting will not take place immediately, a variety of tropical antimicrobial agents and dressings can be used. Examples include Conformant, Acticoat, Aquacel Ag, or warm bacitracin-soaked mesh dressings [<a href="#rid55">55</a>]. The choice can be made based on cost, availability, frequency of dressing changes, and provider familiarity. Depending on the dressing used, these can be left in place from three to seven days postoperatively. (See  <a class="medical medical_review" href="/z/d/html/13509.html" rel="external">"Topical agents and dressings for local burn wound care", section on 'Antimicrobial agents'</a>.)</p><p class="headingAnchor" id="H2561043586"><span class="h1">BURN WOUND CLOSURE</span></p><p class="headingAnchor" id="H547036817"><span class="h2">Timing to grafting</span><span class="headingEndMark"> — </span>Burn wounds are considered closed when autografts have been placed and healed. Early wound closure is associated with decreased severity of hypertrophic scarring, joint contractures, and stiffness and promotes faster rehabilitation [<a href="#rid48">48,70-73</a>]. (See  <a class="medical medical_review" href="/z/d/html/95111.html" rel="external">"Hypertrophic scarring and keloids following burn injuries"</a>.) </p><p>Closure of the burn wounds within the first five days is optimal, which is achievable with immediate grafting after burn wound excision (or shortly thereafter), but burn wound coverage may not always be achievable expeditiously, or with complete success. Although the sooner the better, physiologic and hemodynamic instability can compromise skin graft take and the status of the patient. </p><p class="bulletIndent1"><span class="glyph">●</span>For small TBSA (total body surface area) burns, grafting can follow excision in the same operative setting. </p><p></p><p class="bulletIndent1"><span class="glyph">●</span>For large TBSA burns (&gt;60 percent), the ideal timing is the same, but grafting is often delayed due to lack of donor sites. When necessary, later excision and grafting is reasonable [<a href="#rid74">74</a>]. (See <a class="local">'Managing large burn wounds'</a> below.) </p><p></p><p class="headingAnchor" id="H2059892019"><span class="h2">Autografting</span><span class="headingEndMark"> — </span>For deep burn injuries that are less extensive, autografting may provide adequate coverage. (See  <a class="medical medical_review" href="/z/d/html/15118.html" rel="external">"Skin autografting"</a>.)</p><p>Autografts include split-thickness skin and full-thickness skin transferred from a donor site to a recipient site. Autografts are harvested from healthy, uninjured skin. </p><p>Typically, autografts for the extremity and torso burns are split-thickness skin grafts (STSGs). Common donor sites include the thigh, abdomen, and buttocks. The scalp is also a reliable donor site with rapid healing, particularly in children, allowing for multiple or more frequent harvests from the same site [<a href="#rid75">75</a>]. STSGs are expanded by meshing  (<a class="graphic graphic_picture graphicRef63714" href="/z/d/graphic/63714.html" rel="external">picture 1</a>) according to the area of skin needed. Meshed STSGs can stretch to cover large surface areas but consequently have a higher risk of contraction compared with full-thickness skin grafts (FTSGs), which are not meshed. Nonmeshed (ie, sheet grafts; STSG or FTSG) can be used for smaller burns or cosmetic areas (eg, hands, face). STSGs are harvested with a Zimmer dermatome, which provides a specific uniform thickness. Harvesting the epidermis and a superficial portion of the dermis leaves the remaining epidermal appendages intact to regenerate the epidermal layer, allowing reharvesting at a later time [<a href="#rid54">54</a>]. The ideal wound bed for STSGs is dominated by red granulation tissue, no visible tendon or bone, no obvious sloughing or exudate, no residual necrotic tissue, and no local signs of soft tissue or systemic infection [<a href="#rid76">76</a>]. STSGs can be fixed to the wound bed using fibrin sealants, staples, sutures, or surgical glue. STSGs will quickly adhere to a properly prepared wound bed with revascularization usually occurring between three and five days [<a href="#rid77">77</a>]. (See  <a class="medical medical_review" href="/z/d/html/7938.html" rel="external">"Fibrin sealants"</a> and  <a class="medical medical_review" href="/z/d/html/15118.html" rel="external">"Skin autografting", section on 'Split-thickness skin grafting'</a>.)</p><p>FTSGs are also harvested from a healthy area of tissue but include both the dermal and epidermal layers of skin. These are harvested via surgical excision and are taken from areas of redundant tissue or skin (to facilitate primary closure) like the groin or lower abdomen, or above the supraclavicular space for facial or neck recipient sites to improve color and texture match. The tissue is excised and stripped of any adipose tissue, which is poorly vascularized and, if not properly removed, can compromise engraftment. FTSGs are generally sutured to the prepared wound bed. FTSGs are obviously smaller than STSGs and are only used to address small cosmetic areas due to limited stretch but have a lower rate of contracture. (See  <a class="medical medical_review" href="/z/d/html/15118.html" rel="external">"Skin autografting", section on 'Full-thickness skin grafting'</a>.)</p><p class="headingAnchor" id="H2833482103"><span class="h2">Managing large burn wounds</span><span class="headingEndMark"> — </span>Managing large deep burns (TBSA &gt;60 percent) becomes particularly challenging regarding timing and type of grafting (see <a class="local">'Timing to grafting'</a> above). In addition, for larger TBSA burns, planning includes prioritizing specific areas for patients who are expected to have a prolonged hospital course. Specifically, prioritizing excision and grafting of areas critical for central venous access, arterial lines, and tracheostomy and gastrostomy sites may be indicated when long-term airway and nutritional supplementation are anticipated [<a href="#rid54">54</a>]. Ultimately, the order of excision and prioritization depends on many factors but overall is aimed at optimizing outcomes. </p><p>With the goal of full coverage of the wound, any available unburned skin must be harvested judiciously, but large TBSA deep burns limit the availability of non-burned skin that can be harvested for autograft coverage. (See <a class="local">'Autografting'</a> above.) </p><p>Options for expanding coverage for burn wound closure in the patient with a large TBSA deep burn injury include wide meshing, using the Meek technique, temporary coverage using xenografts or allografts, reharvesting donor sites, and using cultured skin alternatives. </p><p class="bulletIndent1"><span class="glyph">●</span>For large burn wounds, meshed grafts (1:1.5, 1:2, 1:3) are primarily used [<a href="#rid78">78</a>]. The larger the mesh ratio, the larger the surface area the meshed autograft can cover. As an example, a 1:1.5 mesher increases the surface area of the autograft by 50 percent. While meshing facilitates burn wound closure, it may lead to suboptimal cosmetic results due to the healed appearance of the meshed skin. (See  <a class="medical medical_review" href="/z/d/html/15118.html" rel="external">"Skin autografting", section on 'Graft meshing'</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>The Meek technique is a method of skin graft expansion that builds upon the postage stamp technique [<a href="#rid79">79,80</a>]. Skin is harvested from healthy donor sites and divided into 196 micrografts that are placed onto the prepared wound bed using a cork carrier. These micrografts, or skin islands, effectively help cover much larger areas than the additive area of the individual small sizes would suggest [<a href="#rid81">81</a>]. (See  <a class="medical medical_review" href="/z/d/html/15118.html" rel="external">"Skin autografting", section on 'Graft meshing'</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Donor sites, which are very superficial partial-thickness injuries, will heal within two to three weeks, after which they can be reharvested. Until additional donor tissues are available, staged burn wound excisions are temporarily covered using skin substitutes [<a href="#rid36">36,82,83</a>]. Allografts (human cadaveric origin) or xenografts (porcine origin) can be used as temporary bridges for coverage. (See  <a class="medical medical_review" href="/z/d/html/118064.html" rel="external">"Skin substitutes", section on 'General properties and application'</a>.)</p><p></p><p class="bulletIndent1">Allografts may be more effective than xenografts. Allografts have also been used over micrografts to help secure autografts in place and to cover donor sites between harvests. Allografts are available in various sizes and can be meshed similarly like autografts. The use of allografts may help decrease wound size, which in turn can decrease the area of skin that is ultimately harvested for burn wound closure. Although considered temporary, some incorporation of allografts can be expected. When the wound bed is ready for autografting, the allografts are removed. While not considered permanent, some adherence and incorporation into the wound bed could be expected, which can be associated with a moderate-to-significant blood loss. Less-incorporated grafts can essentially be peeled from the wound bed. </p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Cultured skin alternatives, including cultured epithelial autografts (CEAs) and cultured skin substitutes (CSSs), have also be used. </p><p></p><p class="bulletIndent2"><span class="glyph">•</span>CEAs are prepared from cultured keratinocytes from a full-thickness tissue sample of healthy, unburned skin. The cells are prepared and harvested and within a few weeks are readied for transplant [<a href="#rid84">84,85</a>]. </p><p></p><p class="bulletIndent2"><span class="glyph">•</span>CSSs are prepared from epidermal keratinocytes and dermal fibroblasts attached to collagen-glycosaminoglycan substrates [<a href="#rid86">86</a>]. The addition of cultured epidermal melanocytes has restored skin pigmentation in preclinical models.</p><p></p><p class="headingAnchor" id="H1695335430"><span class="h2">Graft dressings</span><span class="headingEndMark"> — </span>Immobilization (ie, extremity splints, bedrest) is advocated to prevent shearing of the skin grafts until fully adherent, which can take up to five days. Tie-over bolster dressings are helpful for securing skin graft dressings on the trunk or near joints by placing nonabsorbable sutures around the wound and tying them to each other across the wound. This provides gentle pressure to help prevent shearing and promote immobility of the graft for engraftment to occur. </p><p>Negative pressure wound therapy (NPWT) can be used to help keep the graft in place while potentially allowing for earlier or more liberal mobilization but is used at the discretion of the burn surgeon. While challenging to place and manage, negative pressure dressings are not limited by the size or location. NPWT helps decrease graft loss [<a href="#rid87">87</a>] and improves the qualitative appearance of STSGs [<a href="#rid88">88</a>]. (See  <a class="medical medical_review" href="/z/d/html/15118.html" rel="external">"Skin autografting", section on 'Graft immobilization'</a>.)</p><p>Extremity dressings can be secured with gauze wraps, and extremity elevation helps prevent edema. Casts or splints over joints and extremities help prevent shearing or graft migration, especially during the first eight hours. After adherence to the wound bed, various dressings can be applied over skin grafts depending on the type of skin graft and site. (See  <a class="medical medical_review" href="/z/d/html/15118.html" rel="external">"Skin autografting", section on 'Limb immobilization and elevation'</a> and  <a class="medical medical_review" href="/z/d/html/15118.html" rel="external">"Skin autografting", section on 'Recipient site dressings and care'</a>.)</p><p class="headingAnchor" id="H1962611804"><span class="h2">Donor site dressings</span><span class="headingEndMark"> — </span>The ideal dressing applied to the donor site protects the wound and promotes epithelialization. The specific dressing used depends on its location. (See  <a class="medical medical_review" href="/z/d/html/15118.html" rel="external">"Skin autografting", section on 'Donor site dressings and care'</a>.)</p><p class="headingAnchor" id="H1736128719"><span class="h1">COMPLICATIONS</span><span class="headingEndMark"> — </span>Burn-wound-related complications include burn wound infection and sepsis, graft failure, and conversion of split-thickness donor sites to full-thickness wounds. Inadequate eschar excision, placement of grafts on ill-prepared tissue beds, shearing and suboptimal graft immobilization, uncontrolled local and systemic infections, shock, and poor postoperative wound care can all contribute to these problems. (See  <a class="medical medical_review" href="/z/d/html/87444.html" rel="external">"Overview of complications of severe burn injury"</a>.)</p><p class="headingAnchor" id="H3247441755"><span class="h2">Burn wound infection</span><span class="headingEndMark"> — </span>Burn wound infections are associated with significant complications that increase morbidity and mortality in burn patients [<a href="#rid39">39</a>]. Similar to the assessment of burn wound depth, typical detection of the beginning of a local infection is based on a daily inspection by an experienced physician. The diagnosis of burn wound infection depends on a tissue biopsy demonstrating a bacterial count of at least 10<sup>5</sup> per 1 cm<sup>2</sup> (1 g) of burn tissue [<a href="#rid89">89-91</a>]. </p><p>The treatment of infected unexcised burn wounds is excision. Topical antimicrobial therapy is first-line treatment for infection involving excised burn wounds and grafted areas in the absence of systemic signs. If signs of systemic infection are present, an empiric intravenous antibiotic regimen tailored to the institution's susceptibility patterns is indicated and discussed separately.(See  <a class="medical medical_review" href="/z/d/html/14985.html" rel="external">"Burn wound infection and sepsis"</a>.) </p><p class="headingAnchor" id="H2720068834"><span class="h2">Graft failure</span><span class="headingEndMark"> — </span>The rate of graft failure for split-thickness sheet and meshed grafts for burn injury is approximately 5 percent [<a href="#rid92">92</a>]. Failure of engraftment is more often a result of an inadequately prepared wound bed than an inadequately prepared skin graft. Both local and systemic factors influence the rate of successful skin grafting [<a href="#rid93">93</a>]. (See  <a class="medical medical_review" href="/z/d/html/112216.html" rel="external">"Risk factors for impaired wound healing and wound complications"</a>.)</p><p>Local factors of the burn wound that are associated with decreased split-thickness skin graft survival include:</p><p class="bulletIndent1"><span class="glyph">●</span>Inadequate vascularity, such as the presence of unvascularized bone or tendon </p><p class="bulletIndent1"><span class="glyph">●</span>Inadequate hemostasis, such as a hematoma or seroma under the graft, which is a major cause [<a href="#rid94">94</a>]</p><p class="bulletIndent1"><span class="glyph">●</span>Excessive mobilization </p><p class="bulletIndent1"><span class="glyph">●</span>Areas of high contact or friction, such as the back, anorectal area, and genitalia</p><p class="bulletIndent1"><span class="glyph">●</span>Local tissue hypoxia caused by smoking or previous radiation</p><p></p><p>Systemic factors may decrease the survival of split-thickness skin grafts much in the same way that wound healing, in general, is affected. These include:</p><p class="bulletIndent1"><span class="glyph">●</span>Advanced patient age</p><p class="bulletIndent1"><span class="glyph">●</span>Malnutrition</p><p class="bulletIndent1"><span class="glyph">●</span>Comorbidities that impact wound healing such as diabetes and immunosuppression</p><p class="bulletIndent1"><span class="glyph">●</span>Glucocorticoid use</p><p class="bulletIndent1"><span class="glyph">●</span>Hemodynamic instability can lead to graft failure and donor site conversion. In particular, one study found that <a class="drug drug_general" data-topicid="10039" href="/z/d/drug information/10039.html" rel="external">vasopressin</a> used in the treatment of shock in burn patients was associated with both [<a href="#rid95">95</a>].</p><p></p><p>The main factor that prevents a complete take of full-thickness skin grafts is the lack of initial adhesion to the recipient site due to the presence of a hematoma or seroma that inhibits revascularization. Even small perforations in the full thickness may not be sufficient to drain accumulating fluid. The same local and systemic factors that decrease the survival of split-thickness skin grafts also decrease the survival of full-thickness skin grafts. </p><p class="headingAnchor" id="H4178984921"><span class="h2">Donor site conversion</span><span class="headingEndMark"> — </span>Harvested skin taken with excess pressure of the dermatome or at a significant thickness may become a full-thickness injury. Some have advocated returning spare harvest skin to donor sites, possibly with additional meshing, as a method to help decrease wound morbidity and healing time [<a href="#rid78">78</a>]. </p><p class="headingAnchor" id="H4288206386"><span class="h1">SOCIETY GUIDELINE LINKS</span><span class="headingEndMark"> — </span>Links to society and government-sponsored guidelines from selected countries and regions around the world are provided separately. (See  <a class="medical medical_society_guidelines" href="/z/d/html/117752.html" rel="external">"Society guideline links: Care of the patient with burn injury"</a>.)</p><p class="headingAnchor" id="H2035527133"><span class="h1">SUMMARY AND RECOMMENDATIONS</span></p><p class="bulletIndent1"><span class="glyph">●</span>Most large total body surface area (TBSA) deep burn injuries (full thickness, deep partial thickness) will require admission to a burn intensive care unit. Such burn injuries are associated with large fluid resuscitation expectations, which can lead to airway compromise and the need for intubation. (See <a class="local">'Introduction'</a> above and <a class="local">'Initial care'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>While cleansing, debridement, and topical wound care is generally sufficient for healing of superficial burns (epidermal [superficial], superficial partial thickness), deep burns (deep partial thickness, full thickness, or deeper) require surgery. Deep burn wounds are considered closed when autografts have been placed and healed, which requires an appropriately prepared wound bed. (See <a class="local">'Early burn excision'</a> above and <a class="local">'Burn wound closure'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>For deep burn injuries, we suggest early excision (within three days from injury), which removes ischemic, necrotic, and potentially infected tissue, rather than awaiting eschar separation (<a class="grade" href="https:///uptodate/show/grade_6" rel="external">Grade 2C</a>). Early burn wound excision may reduce mortality, and it shortens hospital stay. However, hemodynamic and resuscitative parameters must be under control to tolerate an often large blood loss. (See <a class="local">'Efficacy'</a> above and <a class="local">'Timing'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Using tourniquets and topical hemostatic agents during tangential excision of burn wounds can help reduce blood loss and the need for transfusion. An alternative surgical debridement method is fascial excision, which has the advantage of less blood loss, but increased morbidity related to excision of subcutaneous tissue and accompanying lymphatics. (See <a class="local">'Techniques'</a> above and <a class="local">'Hemostasis'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>We suggest definitive burn wound coverage (autografting) at the time of burn wound excision, if possible (<a class="grade" href="https:///uptodate/show/grade_6" rel="external">Grade 2C</a>). Burn wound closure (ie, autografts have been placed and have healed) within the first five days is optimal, but this is often difficult to achieve in patients with extensive burns, or with concurrent traumatic injuries. Excised deep burn wounds that are not immediately grafted can be covered with allografts or other skin substitutes. Early wound closure is associated with decreased severity of hypertrophic scarring, joint contractures, and stiffness, and promotes faster rehabilitation. (See <a class="local">'Burn wound closure'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Large TBSA burns limit the availability of non-burned skin that can be harvested for immediate coverage. Strategies to manage large TBSA burns include (see <a class="local">'Managing large burn wounds'</a> above): </p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Meshing split-thickness skin grafts</p><p class="bulletIndent2"><span class="glyph">•</span>Using the Meek technique</p><p class="bulletIndent2"><span class="glyph">•</span>Reharvesting donor sites</p><p class="bulletIndent2"><span class="glyph">•</span>Using allografts as temporary coverage, until donor sites are ready for reharvesting </p><p class="bulletIndent2"><span class="glyph">•</span>Using cultured skin alternatives (eg, cultured epithelial autografts, cultured skin substitutes) </p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Immobilization of the grafted sites is important to prevent shearing of the grafts they adhere to. Negative pressure wound therapy can be used to help keep the graft in place while potentially allowing for earlier or more liberal mobilization. (See <a class="local">'Graft dressings'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Complications of burn wound care include ischemia from inadequate escharotomy, burn wound infection and sepsis, graft failure, and conversion of split-thickness donor sites to full thickness injuries. The rate of graft failure for split-thickness grafts in burn injury is approximately 5 percent. (See <a class="local">'Escharotomy'</a> above and <a class="local">'Complications'</a> above.)</p></div><div class="headingAnchor" id="references"><ol id="reference"><li><a class="nounderline abstract_t">Tocco-Tussardi I, Presman B, Huss F. Want Correct Percentage of TBSA Burned? Let a Layman Do the Assessment. J Burn Care Res 2018; 39:295.</a></li><li><a class="nounderline abstract_t">Knaysi GA, Crikelair GF, Cosman B. The role of nines: its history and accuracy. Plast Reconstr Surg 1968; 41:560.</a></li><li><a class="nounderline abstract_t">Rossiter ND, Chapman P, Haywood IA. How big is a hand? Burns 1996; 22:230.</a></li><li><a class="nounderline abstract_t">Lund C, Browder N. The estimation of areas of burns. Surg Gynaecol Obstet 1944; 79:352.</a></li><li><a class="nounderline abstract_t">Heimbach D, Engrav L, Grube B, Marvin J. Burn depth: a review. World J Surg 1992; 16:10.</a></li><li><a class="nounderline abstract_t">Heimbach DM, Afromowitz MA, Engrav LH, et al. Burn depth estimation--man or machine. J Trauma 1984; 24:373.</a></li><li><a class="nounderline abstract_t">Mileski WJ, Atiles L, Purdue G, et al. Serial measurements increase the accuracy of laser Doppler assessment of burn wounds. J Burn Care Rehabil 2003; 24:187.</a></li><li><a class="nounderline abstract_t">Still JM, Law EJ, Klavuhn KG, et al. Diagnosis of burn depth using laser-induced indocyanine green fluorescence: a preliminary clinical trial. Burns 2001; 27:364.</a></li><li><a class="nounderline abstract_t">Watts AM, Tyler MP, Perry ME, et al. Burn depth and its histological measurement. Burns 2001; 27:154.</a></li><li><a class="nounderline abstract_t">Niazi ZB, Essex TJ, Papini R, et al. New laser Doppler scanner, a valuable adjunct in burn depth assessment. Burns 1993; 19:485.</a></li><li><a class="nounderline abstract_t">Devgan L, Bhat S, Aylward S, Spence RJ. Modalities for the assessment of burn wound depth. J Burns Wounds 2006; 5:e2.</a></li><li><a class="nounderline abstract_t">Kao CC, Garner WL. Acute burns. Plast Reconstr Surg 2000; 105:2482.</a></li><li><a class="nounderline abstract_t">JACKSON DM. [The diagnosis of the depth of burning]. Br J Surg 1953; 40:588.</a></li><li><a class="nounderline abstract_t">Krieger Y, Rosenberg L, Lapid O, et al. Escharotomy using an enzymatic debridement agent for treating experimental burn-induced compartment syndrome in an animal model. J Trauma 2005; 58:1259.</a></li><li><a class="nounderline abstract_t">Monafo WW, Brentano L, Gravens DL, et al. Gas gangrene and mixed-clostridial infections of muscle complicating deep thermal burns. Arch Surg 1966; 92:212.</a></li><li><a class="nounderline abstract_t">Bardakjian VB, Kenney JG, Edgerton MT, Morgan RF. Pulse oximetry for vascular monitoring in burned upper extremities. J Burn Care Rehabil 1988; 9:63.</a></li><li><a class="nounderline abstract_t">Sánchez-Sánchez M, García-de-Lorenzo A, Asensio MJ. First resuscitation of critical burn patients: progresses and problems. Med Intensiva 2016; 40:118.</a></li><li><a class="nounderline abstract_t">Blumetti J, Hunt JL, Arnoldo BD, et al. The Parkland formula under fire: is the criticism justified? J Burn Care Res 2008; 29:180.</a></li><li><a class="nounderline abstract_t">Friedrich JB, Sullivan SR, Engrav LH, et al. Is supra-Baxter resuscitation in burn patients a new phenomenon? Burns 2004; 30:464.</a></li><li><a class="nounderline abstract_t">Saffle JI. The phenomenon of "fluid creep" in acute burn resuscitation. J Burn Care Res 2007; 28:382.</a></li><li><a class="nounderline abstract_t">Eljaiek R, Heylbroeck C, Dubois MJ. Albumin administration for fluid resuscitation in burn patients: A systematic review and meta-analysis. Burns 2017; 43:17.</a></li><li><a class="nounderline abstract_t">Cartotto R, Callum J. A Review on the Use of Plasma During Acute Burn Resuscitation. J Burn Care Res 2020; 41:433.</a></li><li><a class="nounderline abstract_t">Pruitt BA Jr. Protection from excessive resuscitation: "pushing the pendulum back". J Trauma 2000; 49:567.</a></li><li><a class="nounderline abstract_t">Kao Y, Loh EW, Hsu CC, et al. Fluid Resuscitation in Patients With Severe Burns: A Meta-analysis of Randomized Controlled Trials. Acad Emerg Med 2018; 25:320.</a></li><li><a class="nounderline abstract_t">Perel P, Roberts I, Ker K. Colloids versus crystalloids for fluid resuscitation in critically ill patients. Cochrane Database Syst Rev 2013; :CD000567.</a></li><li><a class="nounderline abstract_t">MacLennan SE, Wells MD, Neale HW. Reconstruction of the burned breast. Clin Plast Surg 2000; 27:113.</a></li><li><a class="nounderline abstract_t">Chung KK, Blackbourne LH, Wolf SE, et al. Evolution of burn resuscitation in operation Iraqi freedom. J Burn Care Res 2006; 27:606.</a></li><li><a class="nounderline abstract_t">Johnson RM, Richard R. Partial-thickness burns: identification and management. Adv Skin Wound Care 2003; 16:178.</a></li><li><a class="nounderline abstract_t">Lloyd EC, Rodgers BC, Michener M, Williams MS. Outpatient burns: prevention and care. Am Fam Physician 2012; 85:25.</a></li><li><a class="nounderline abstract_t">Roberts JR. Minor burns: initial therapy. Emerg Med News 2003; 25:28.</a></li><li><a class="nounderline abstract_t">Xiao-Wu W, Herndon DN, Spies M, et al. Effects of delayed wound excision and grafting in severely burned children. Arch Surg 2002; 137:1049.</a></li><li><a class="nounderline abstract_t">Kennedy P, Brammah S, Wills E. Burns, biofilm and a new appraisal of burn wound sepsis. Burns 2010; 36:49.</a></li><li><a class="nounderline abstract_t">Saaiq M, Zaib S, Ahmad S. Early excision and grafting versus delayed excision and grafting of deep thermal burns up to 40% total body surface area: a comparison of outcome. Ann Burns Fire Disasters 2012; 25:143.</a></li><li><a class="nounderline abstract_t">Engrav LH, Heimbach DM, Reus JL, et al. Early excision and grafting vs. nonoperative treatment of burns of indeterminant depth: a randomized prospective study. J Trauma 1983; 23:1001.</a></li><li><a class="nounderline abstract_t">Thompson P, Herndon DN, Abston S, Rutan T. Effect of early excision on patients with major thermal injury. J Trauma 1987; 27:205.</a></li><li><a class="nounderline abstract_t">Herndon DN, Barrow RE, Rutan RL, et al. A comparison of conservative versus early excision. Therapies in severely burned patients. Ann Surg 1989; 209:547.</a></li><li><a class="nounderline abstract_t">Tompkins RG, Burke JF, Schoenfeld DA, et al. Prompt eschar excision: a treatment system contributing to reduced burn mortality. A statistical evaluation of burn care at the Massachusetts General Hospital (1974-1984). Ann Surg 1986; 204:272.</a></li><li><a class="nounderline abstract_t">Ong YS, Samuel M, Song C. Meta-analysis of early excision of burns. Burns 2006; 32:145.</a></li><li><a class="nounderline abstract_t">Cancio LC, Barillo DJ, Kearns RD, et al. Guidelines for Burn Care Under Austere Conditions: Surgical and Nonsurgical Wound Management. J Burn Care Res 2017; 38:203.</a></li><li><a class="nounderline abstract_t">Barillo DJ. ﻿Topical antimicrobials in burn wound care: a recent history﻿﻿﻿﻿. Wounds 2008; 20:192.</a></li><li><a class="nounderline abstract_t">Barillo DJ. Using mafenide acetate in acute and chronic wounds. Ostomy Wound Manage 2002.</a></li><li><a class="nounderline abstract_t">Pruitt BA Jr, O'Neill JA Jr, Moncrief JA, Lindberg RB. Successful control of burn-wound sepsis. JAMA 1968; 203:1054.</a></li><li><a class="nounderline abstract_t">MOYER CA, BRENTANO L, GRAVENS DL, et al. TREATMENT OF LARGE HUMAN BURNS WITH 0.5 PER CENT SILVER NITRATE SOLUTION. Arch Surg 1965; 90:812.</a></li><li><a class="nounderline abstract_t">Fox CL Jr. Silver sulfadiazine--a new topical therapy for Pseudomonas in burns. Therapy of Pseudomonas infection in burns. Arch Surg 1968; 96:184.</a></li><li class="breakAll">Moncrief JA. Topical antibacterial treatment of the burn wound. In: Burns, a Team Approach, Artz CP, Moncrief JA, Pruitt BA (Eds), Saunders, Philadelphia 1979.</li><li><a class="nounderline abstract_t">Rutan TC, Herndon DN, Van Osten T, Abston S. Metabolic rate alterations in early excision and grafting versus conservative treatment. J Trauma 1986; 26:140.</a></li><li><a class="nounderline abstract_t">Hart DW, Wolf SE, Mlcak R, et al. Persistence of muscle catabolism after severe burn. Surgery 2000; 128:312.</a></li><li><a class="nounderline abstract_t">Salisbury RE, Wright P. Evaluation of early excision of dorsal burns of the hand. Plast Reconstr Surg 1982; 69:670.</a></li><li><a class="nounderline abstract_t">Baux S, Mimoun M, Kirsch JM, et al. Recent burns of the hand. Early excision-graft versus conventional treatment. A retrospective study during two years. Ann Chir Main 1987; 6:276.</a></li><li><a class="nounderline abstract_t">Munster AM, Smith-Meek M, Sharkey P. The effect of early surgical intervention on mortality and cost-effectiveness in burn care, 1978-91. Burns 1994; 20:61.</a></li><li><a class="nounderline abstract_t">Klein MB, Hunter S, Heimbach DM, et al. The Versajet water dissector: a new tool for tangential excision. J Burn Care Rehabil 2005; 26:483.</a></li><li><a class="nounderline abstract_t">EVANS AJ. Use of the humby knife in the excision of burns. Br Med J 1952; 2:979.</a></li><li><a class="nounderline abstract_t">Hunt JL, Sato R, Baxter CR. Early tangential excision and immediate mesh autografting of deep dermal hand burns. Ann Surg 1979; 189:147.</a></li><li><a class="nounderline abstract_t">Daugherty THF, Ross A, Neumeister MW. Surgical Excision of Burn Wounds: Best Practices Using Evidence-Based Medicine. Clin Plast Surg 2017; 44:619.</a></li><li><a class="nounderline abstract_t">Mosier MJ, Gibran NS. Surgical excision of the burn wound. Clin Plast Surg 2009; 36:617.</a></li><li><a class="nounderline abstract_t">Kakagia DD, Karadimas EJ. The Efficacy of Versajet™ Hydrosurgery System in Burn Surgery. A Systematic Review. J Burn Care Res 2018; 39:188.</a></li><li><a class="nounderline abstract_t">Jeffery SL. Device related tangential excision in burns. Injury 2007; 38 Suppl 5:S35.</a></li><li><a class="nounderline abstract_t">Cubison TC, Pape SA, Jeffery SL. Dermal preservation using the Versajet hydrosurgery system for debridement of paediatric burns. Burns 2006; 32:714.</a></li><li><a class="nounderline abstract_t">Matsumura H, Nozaki M, Watanabe K, et al. The estimation of tissue loss during tangential hydrosurgical debridement. Ann Plast Surg 2012; 69:521.</a></li><li><a class="nounderline abstract_t">Legemate CM, Kwa KAA, Goei H, et al. Hydrosurgical and conventional debridement of burns: randomized clinical trial. Br J Surg 2022; 109:332.</a></li><li><a class="nounderline abstract_t">Edmondson SJ, Ali Jumabhoy I, Murray A. Time to start putting down the knife: A systematic review of burns excision tools of randomised and non-randomised trials. Burns 2018; 44:1721.</a></li><li><a class="nounderline abstract_t">Giudice G, Filoni A, Maggio G, et al. Cost Analysis of a Novel Enzymatic Debriding Agent for Management of Burn Wounds. Biomed Res Int 2017; 2017:9567498.</a></li><li><a class="nounderline abstract_t">Rosenberg L, Krieger Y, Bogdanov-Berezovski A, et al. A novel rapid and selective enzymatic debridement agent for burn wound management: a multi-center RCT. Burns 2014; 40:466.</a></li><li><a class="nounderline abstract_t">O'Mara MS, Goel A, Recio P, et al. The use of tourniquets in the excision of unexsanguinated extremity burn wounds. Burns 2002; 28:684.</a></li><li><a class="nounderline abstract_t">Aballay AM, Recio P, Slater H, et al. The use of esmarch exsanguination for the treatment of extremity wound burns. Ann Burns Fire Disasters 2007; 20:22.</a></li><li><a class="nounderline abstract_t">Foster K. The use of fibrin sealant in burn operations. Surgery 2007; 142:S50.</a></li><li><a class="nounderline abstract_t">Foster K, Greenhalgh D, Gamelli RL, et al. Efficacy and safety of a fibrin sealant for adherence of autologous skin grafts to burn wounds: results of a phase 3 clinical study. J Burn Care Res 2008; 29:293.</a></li><li><a class="nounderline abstract_t">Gibran N, Luterman A, Herndon D, et al. Comparison of fibrin sealant and staples for attaching split-thickness autologous sheet grafts in patients with deep partial- or full-thickness burn wounds: a phase 1/2 clinical study. J Burn Care Res 2007; 28:401.</a></li><li><a class="nounderline abstract_t">Miller R, Wormald JCR, Wade RG, Collins DP. Systematic review of fibrin glue in burn wound reconstruction. Br J Surg 2019; 106:165.</a></li><li><a class="nounderline abstract_t">Singer AJ, Toussaint J, Chung WT, et al. Early versus Delayed Excision and Grafting of Full-Thickness Burns in a Porcine Model: A Randomized Study. Plast Reconstr Surg 2016; 137:972e.</a></li><li><a class="nounderline abstract_t">Omar MT, Hassan AA. Evaluation of hand function after early excision and skin grafting of burns versus delayed skin grafting: a randomized clinical trial. Burns 2011; 37:707.</a></li><li><a class="nounderline abstract_t">Atiyeh BS, Dham R, Kadry M, et al. Benefit-cost analysis of moist exposed burn ointment. Burns 2002; 28:659.</a></li><li><a class="nounderline abstract_t">Ramzy PI, Barret JP, Herndon DN. Thermal injury. Crit Care Clin 1999; 15:333.</a></li><li><a class="nounderline abstract_t">Prasanna M, Mishra P, Thomas C. Delayed primary closure of the burn wounds. Burns 2004; 30:169.</a></li><li><a class="nounderline abstract_t">Roodbergen DT, Vloemans AF, Rashaan ZM, et al. The scalp as a donor site for skin grafting in burns: retrospective study on complications. Burns Trauma 2016; 4:20.</a></li><li><a class="nounderline abstract_t">Aerden D, Bosmans I, Vanmierlo B, et al. Skin grafting the contaminated wound bed: reassessing the role of the preoperative swab. J Wound Care 2013; 22:85.</a></li><li><a class="nounderline abstract_t">Donato MC, Novicki DC, Blume PA. Skin grafting. Historic and practical approaches. Clin Podiatr Med Surg 2000; 17:561.</a></li><li><a class="nounderline abstract_t">Henderson J, Arya R, Gillespie P. Skin graft meshing, over-meshing and cross-meshing. Int J Surg 2012; 10:547.</a></li><li><a class="nounderline abstract_t">MEEK CP. Successful microdermagrafting using the Meek-Wall microdermatome. Am J Surg 1958; 96:557.</a></li><li><a class="nounderline abstract_t">Chih-chun Y, Tsi-siang S, Wei-shia X. A Chinese concept of treatment of extensive third-degree burns. Plast Reconstr Surg 1982; 70:238.</a></li><li><a class="nounderline abstract_t">Medina A, Riegel T, Nystad D, Tredget EE. Modified Meek Micrografting Technique for Wound Coverage in Extensive Burn Injuries. J Burn Care Res 2016; 37:305.</a></li><li><a class="nounderline abstract_t">Debels H, Hamdi M, Abberton K, Morrison W. Dermal matrices and bioengineered skin substitutes: a critical review of current options. Plast Reconstr Surg Glob Open 2015; 3:e284.</a></li><li><a class="nounderline abstract_t">Elmasry M, Steinvall I, Thorfinn J, et al. Staged excisions of moderate-sized burns compared with total excision with immediate autograft: an evaluation of two strategies. Int J Burns Trauma 2017; 7:6.</a></li><li><a class="nounderline abstract_t">Rheinwald JG, Green H. Serial cultivation of strains of human epidermal keratinocytes: the formation of keratinizing colonies from single cells. Cell 1975; 6:331.</a></li><li><a class="nounderline abstract_t">Sood R, Roggy D, Zieger M, et al. Cultured epithelial autografts for coverage of large burn wounds in eighty-eight patients: the Indiana University experience. J Burn Care Res 2010; 31:559.</a></li><li><a class="nounderline abstract_t">Boyce ST, Kagan RJ, Greenhalgh DG, et al. Cultured skin substitutes reduce requirements for harvesting of skin autograft for closure of excised, full-thickness burns. J Trauma 2006; 60:821.</a></li><li><a class="nounderline abstract_t">Webster J, Scuffham P, Stankiewicz M, Chaboyer WP. Negative pressure wound therapy for skin grafts and surgical wounds healing by primary intention. Cochrane Database Syst Rev 2014; :CD009261.</a></li><li><a class="nounderline abstract_t">Moisidis E, Heath T, Boorer C, et al. A prospective, blinded, randomized, controlled clinical trial of topical negative pressure use in skin grafting. Plast Reconstr Surg 2004; 114:917.</a></li><li><a class="nounderline abstract_t">Ono S, Imai R, Ida Y, et al. Increased wound pH as an indicator of local wound infection in second degree burns. Burns 2015; 41:820.</a></li><li><a class="nounderline abstract_t">Rashaan ZM, Krijnen P, Klamer RR, et al. Nonsilver treatment vs. silver sulfadiazine in treatment of partial-thickness burn wounds in children: a systematic review and meta-analysis. Wound Repair Regen 2014; 22:473.</a></li><li><a class="nounderline abstract_t">Schultz L, Walker SA, Elligsen M, et al. Identification of predictors of early infection in acute burn patients. Burns 2013; 39:1355.</a></li><li><a class="nounderline abstract_t">Archer SB, Henke A, Greenhalgh DG, Warden GD. The use of sheet autografts to cover extensive burns in patients. J Burn Care Rehabil 1998; 19:33.</a></li><li class="breakAll">Thorne, C. Techniques and principles in plastic surgery. In: Grabb and Smith's Plastic Surgery, Wolters Kluwer, 2007. p.8.</li><li><a class="nounderline abstract_t">Nervi C, Gamelli RL, Greenhalgh DG, et al. A multicenter clinical trial to evaluate the topical hemostatic efficacy of fibrin sealant in burn patients. J Burn Care Rehabil 2001; 22:99.</a></li><li><a class="nounderline abstract_t">Cartotto R, McGibney K, Smith T, Abadir A. Vasopressin for the septic burn patient. Burns 2007; 33:441.</a></li></ol></div><div id="topicVersionRevision">Topic 114178 Version 12.0</div></div>
<div class="row">
<div class="col-12">
<h4 style="text-align: center;padding: 20px;color: cadetblue;">References</h4>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/28877135" id="rid0" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>1 : Want Correct Percentage of TBSA Burned? Let a Layman Do the Assessment.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/5654897" id="rid1" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>2 : The role of nines: its history and accuracy.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/8726264" id="rid2" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>3 : How big is a hand?</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/" id="rid3" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>4 : The estimation of areas of burns</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/1290249" id="rid4" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>5 : Burn depth: a review.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/6371255" id="rid5" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>6 : Burn depth estimation--man or machine.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/14501411" id="rid6" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>7 : Serial measurements increase the accuracy of laser Doppler assessment of burn wounds.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/11348745" id="rid7" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>8 : Diagnosis of burn depth using laser-induced indocyanine green fluorescence: a preliminary clinical trial.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/11226654" id="rid8" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>9 : Burn depth and its histological measurement.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/8292231" id="rid9" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>10 : New laser Doppler scanner, a valuable adjunct in burn depth assessment.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/16921415" id="rid10" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>11 : Modalities for the assessment of burn wound depth.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/10845306" id="rid11" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>12 : Acute burns.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/13059343" id="rid12" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>13 : [The diagnosis of the depth of burning].</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/15995479" id="rid13" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>14 : Escharotomy using an enzymatic debridement agent for treating experimental burn-induced compartment syndrome in an animal model.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/5902850" id="rid14" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>15 : Gas gangrene and mixed-clostridial infections of muscle complicating deep thermal burns.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/2965708" id="rid15" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>16 : Pulse oximetry for vascular monitoring in burned upper extremities.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/26873418" id="rid16" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>17 : First resuscitation of critical burn patients: progresses and problems.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/18182919" id="rid17" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>18 : The Parkland formula under fire: is the criticism justified?</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/15225912" id="rid18" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>19 : Is supra-Baxter resuscitation in burn patients a new phenomenon?</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/17438489" id="rid19" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>20 : The phenomenon of "fluid creep" in acute burn resuscitation.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/27613476" id="rid20" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>21 : Albumin administration for fluid resuscitation in burn patients: A systematic review and meta-analysis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/31734693" id="rid21" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>22 : A Review on the Use of Plasma During Acute Burn Resuscitation.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/11003341" id="rid22" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>23 : Protection from excessive resuscitation: "pushing the pendulum back".</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/29024269" id="rid23" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>24 : Fluid Resuscitation in Patients With Severe Burns: A Meta-analysis of Randomized Controlled Trials.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/23450531" id="rid24" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>25 : Colloids versus crystalloids for fluid resuscitation in critically ill patients.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/10665360" id="rid25" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>26 : Reconstruction of the burned breast.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/16998392" id="rid26" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>27 : Evolution of burn resuscitation in operation Iraqi freedom.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/12897674" id="rid27" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>28 : Partial-thickness burns: identification and management.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/22230304" id="rid28" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>29 : Outpatient burns: prevention and care.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/" id="rid29" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>30 : Minor burns: initial therapy</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/12215159" id="rid30" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>31 : Effects of delayed wound excision and grafting in severely burned children.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/19523770" id="rid31" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>32 : Burns, biofilm and a new appraisal of burn wound sepsis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/23467391" id="rid32" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>33 : Early excision and grafting versus delayed excision and grafting of deep thermal burns up to 40% total body surface area: a comparison of outcome.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/6355500" id="rid33" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>34 : Early excision and grafting vs. nonoperative treatment of burns of indeterminant depth: a randomized prospective study.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/3820353" id="rid34" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>35 : Effect of early excision on patients with major thermal injury.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/2650643" id="rid35" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>36 : A comparison of conservative versus early excision. Therapies in severely burned patients.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/3753058" id="rid36" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>37 : Prompt eschar excision: a treatment system contributing to reduced burn mortality. A statistical evaluation of burn care at the Massachusetts General Hospital (1974-1984).</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/16414197" id="rid37" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>38 : Meta-analysis of early excision of burns.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/27355660" id="rid38" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>39 : Guidelines for Burn Care Under Austere Conditions: Surgical and Nonsurgical Wound Management.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/25942608" id="rid39" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>40 : ﻿Topical antimicrobials in burn wound care: a recent history﻿﻿﻿﻿.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/" id="rid40" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>41 : Using mafenide acetate in acute and chronic wounds</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/5694367" id="rid41" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>42 : Successful control of burn-wound sepsis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/14333527" id="rid42" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>43 : TREATMENT OF LARGE HUMAN BURNS WITH 0.5 PER CENT SILVER NITRATE SOLUTION.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/5638080" id="rid43" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>44 : Silver sulfadiazine--a new topical therapy for Pseudomonas in burns. Therapy of Pseudomonas infection in burns.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/5638080" id="rid44" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>45 : Silver sulfadiazine--a new topical therapy for Pseudomonas in burns. Therapy of Pseudomonas infection in burns.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/3944837" id="rid45" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>46 : Metabolic rate alterations in early excision and grafting versus conservative treatment.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/10923010" id="rid46" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>47 : Persistence of muscle catabolism after severe burn.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/7041150" id="rid47" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>48 : Evaluation of early excision of dorsal burns of the hand.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/3329489" id="rid48" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>49 : Recent burns of the hand. Early excision-graft versus conventional treatment. A retrospective study during two years.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/8148080" id="rid49" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>50 : The effect of early surgical intervention on mortality and cost-effectiveness in burn care, 1978-91.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/16278562" id="rid50" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>51 : The Versajet water dissector: a new tool for tangential excision.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/12987711" id="rid51" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>52 : Use of the humby knife in the excision of burns.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/371555" id="rid52" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>53 : Early tangential excision and immediate mesh autografting of deep dermal hand burns.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/28576251" id="rid53" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>54 : Surgical Excision of Burn Wounds: Best Practices Using Evidence-Based Medicine.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/19793556" id="rid54" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>55 : Surgical excision of the burn wound.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/28383304" id="rid55" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>56 : The Efficacy of Versajet™Hydrosurgery System in Burn Surgery. A Systematic Review.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/18061188" id="rid56" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>57 : Device related tangential excision in burns.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/16849034" id="rid57" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>58 : Dermal preservation using the Versajet hydrosurgery system for debridement of paediatric burns.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/23044757" id="rid58" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>59 : The estimation of tissue loss during tangential hydrosurgical debridement.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/35237788" id="rid59" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>60 : Hydrosurgical and conventional debridement of burns: randomized clinical trial.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/29456099" id="rid60" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>61 : Time to start putting down the knife: A systematic review of burns excision tools of randomised and non-randomised trials.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/28293640" id="rid61" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>62 : Cost Analysis of a Novel Enzymatic Debriding Agent for Management of Burn Wounds.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/24074719" id="rid62" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>63 : A novel rapid and selective enzymatic debridement agent for burn wound management: a multi-center RCT.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/12417166" id="rid63" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>64 : The use of tourniquets in the excision of unexsanguinated extremity burn wounds.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/21991062" id="rid64" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>65 : The use of esmarch exsanguination for the treatment of extremity wound burns.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/18019939" id="rid65" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>66 : The use of fibrin sealant in burn operations.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/18354285" id="rid66" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>67 : Efficacy and safety of a fibrin sealant for adherence of autologous skin grafts to burn wounds: results of a phase 3 clinical study.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/17438504" id="rid67" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>68 : Comparison of fibrin sealant and staples for attaching split-thickness autologous sheet grafts in patients with deep partial- or full-thickness burn wounds: a phase 1/2 clinical study.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/30724361" id="rid68" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>69 : Systematic review of fibrin glue in burn wound reconstruction.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/27219266" id="rid69" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>70 : Early versus Delayed Excision and Grafting of Full-Thickness Burns in a Porcine Model: A Randomized Study.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/21276660" id="rid70" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>71 : Evaluation of hand function after early excision and skin grafting of burns versus delayed skin grafting: a randomized clinical trial.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/12417161" id="rid71" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>72 : Benefit-cost analysis of moist exposed burn ointment.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/10331132" id="rid72" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>73 : Thermal injury.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/15019128" id="rid73" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>74 : Delayed primary closure of the burn wounds.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/27574689" id="rid74" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>75 : The scalp as a donor site for skin grafting in burns: retrospective study on complications.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/23665663" id="rid75" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>76 : Skin grafting the contaminated wound bed: reassessing the role of the preoperative swab.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/11070796" id="rid76" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>77 : Skin grafting. Historic and practical approaches.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/22960468" id="rid77" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>78 : Skin graft meshing, over-meshing and cross-meshing.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/13571547" id="rid78" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>79 : Successful microdermagrafting using the Meek-Wall microdermatome.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/7048371" id="rid79" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>80 : A Chinese concept of treatment of extensive third-degree burns.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/27355651" id="rid80" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>81 : Modified Meek Micrografting Technique for Wound Coverage in Extensive Burn Injuries.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/25674365" id="rid81" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>82 : Dermal matrices and bioengineered skin substitutes: a critical review of current options.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/28123862" id="rid82" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>83 : Staged excisions of moderate-sized burns compared with total excision with immediate autograft: an evaluation of two strategies.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/1052771" id="rid83" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>84 : Serial cultivation of strains of human epidermal keratinocytes: the formation of keratinizing colonies from single cells.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/20616650" id="rid84" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>85 : Cultured epithelial autografts for coverage of large burn wounds in eighty-eight patients: the Indiana University experience.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/16612303" id="rid85" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>86 : Cultured skin substitutes reduce requirements for harvesting of skin autograft for closure of excised, full-thickness burns.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/25287701" id="rid86" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>87 : Negative pressure wound therapy for skin grafts and surgical wounds healing by primary intention.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/15468399" id="rid87" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>88 : A prospective, blinded, randomized, controlled clinical trial of topical negative pressure use in skin grafting.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/25468471" id="rid88" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>89 : Increased wound pH as an indicator of local wound infection in second degree burns.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/24899251" id="rid89" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>90 : Nonsilver treatment vs. silver sulfadiazine in treatment of partial-thickness burn wounds in children: a systematic review and meta-analysis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/23664774" id="rid90" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>91 : Identification of predictors of early infection in acute burn patients.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/9502022" id="rid91" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>92 : The use of sheet autografts to cover extensive burns in patients.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/9502022" id="rid92" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>93 : The use of sheet autografts to cover extensive burns in patients.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/11302613" id="rid93" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>94 : A multicenter clinical trial to evaluate the topical hemostatic efficacy of fibrin sealant in burn patients.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/17379416" id="rid94" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>95 : Vasopressin for the septic burn patient.</p>
</a>
</div>
</div>
</div>
</div>
</section>
</section>
<!-- End Main Menu Area -->
<!-- Start Search Popup Area -->
<!-- End Footer Area -->
<!-- Back to top -->
<a class="scrolltop" href="#top"><i class="icofont-hand-drawn-up"></i></a>
<!-- End Back to top -->
<!-- jQuery Min JS -->
<!-- Prpper JS -->
<!-- Bootstrap Min JS -->
<!-- Classy Nav Min Js -->
<!-- Owl Carousel Min Js -->
<!-- Magnific Popup JS -->
<!-- CounterUp JS -->
<!-- Waypoints JS -->
<!-- Form Validator Min JS -->
<!-- Contact Form Min JS -->
<!-- Main JS -->
<!-- Global site tag (gtag.js) - Google Analytics -->
</body>
</html>
